找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Artemisinin and Nitric Oxide; Mechanisms and Impli Qing-Ping Zeng Book 2015 The Author(s) 2015 Aging-Related Disease.Artemisinin-Mediated A

[復(fù)制鏈接]
樓主: Aggrief
21#
發(fā)表于 2025-3-25 03:55:10 | 只看該作者
https://doi.org/10.1007/978-3-030-36606-3ttern from biosynthesis to degradation. ART also mimics CR to compromise mouse?telomere shortening by upregulating antioxidative enzymes for effective ROS scavenging, which is followed by the alleviation of DNA damage and downregulation of tumor suppressors. This is the first time for?having found ART exerting an antiaging role.
22#
發(fā)表于 2025-3-25 09:15:59 | 只看該作者
23#
發(fā)表于 2025-3-25 15:12:16 | 只看該作者
24#
發(fā)表于 2025-3-25 16:32:00 | 只看該作者
25#
發(fā)表于 2025-3-25 22:10:48 | 只看該作者
ART for Antibacterial Infection,n antibiotic sensitizing role through inhibiting bNOS and CAT. Either in vivo or in vitro, ART can increase the bacteriocidal activity of antibiotics by abrogating the beneficial NO and enhancing the harmful H.O., demonstrating a potential role in combating multidrug?resistant bacteria.
26#
發(fā)表于 2025-3-26 00:28:45 | 只看該作者
27#
發(fā)表于 2025-3-26 08:02:04 | 只看該作者
ART for Antiaging,ttern from biosynthesis to degradation. ART also mimics CR to compromise mouse?telomere shortening by upregulating antioxidative enzymes for effective ROS scavenging, which is followed by the alleviation of DNA damage and downregulation of tumor suppressors. This is the first time for?having found ART exerting an antiaging role.
28#
發(fā)表于 2025-3-26 09:28:25 | 只看該作者
29#
發(fā)表于 2025-3-26 12:52:49 | 只看該作者
30#
發(fā)表于 2025-3-26 17:35:27 | 只看該作者
Eyeblink Classical Conditioning in Amnesia,se of ART can kill cancer cells and bacteria through compromising protective NO production. A low dose of ART can mimic CR to extend lifespan and reduce weight by triggering mitochondrial biogenesis. Therefore, ART can exert versatile beneficial effects on human health in addition to antimalaria.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 09:26
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
商南县| 安义县| 麟游县| 封开县| 江口县| 南郑县| 仁寿县| 长沙县| 乌兰察布市| 镇康县| 永善县| 常熟市| 九龙县| 蓬莱市| 观塘区| 南皮县| 北碚区| 枝江市| 化隆| 上虞市| 都匀市| 开封县| 广宗县| 大田县| 贵定县| 寿阳县| 邵阳县| 拉孜县| 永定县| 三亚市| 康乐县| 新宾| 军事| 南投市| 双城市| 余江县| 桐乡市| 新田县| 轮台县| 肥城市| 共和县|